<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Appili Therapeutics Enrolls Participants in Clinical Trials
Image Overlay - Appili Therapeutics Enrolls Participants in Clinical Trials

Appili Therapeutics Enrolls Participants in Clinical Trials

October 29, 2020

Appili Therapeutics Enrolls Participants in Clinical Trials

Canada-based Appili Therapeutics has enrolled and dosed the first cluster of participants in its Phase II CONTROL COVID-19 clinical trial of favipiravi, developed by FUJIFILM Toyama Chemical. Yourway has a local depot that’s 6,000 square feet conveniently located in Toronto, Canada to better serve the clinical trial needs in the country.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat
Come chat with us!
Hello! How can I help you?